Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in TaxesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InflaRx (IFRX) Change in Working Capital (2022 - 2025)

Historic Change in Working Capital for InflaRx (IFRX) over the last 4 years, with Q3 2025 value amounting to $6.3 million.

  • InflaRx's Change in Working Capital fell 9999.99% to $6.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 million, marking a year-over-year decrease of 9999.99%. This contributed to the annual value of $5.5 million for FY2024, which is 2717.86% up from last year.
  • Per InflaRx's latest filing, its Change in Working Capital stood at $6.3 million for Q3 2025, which was down 9999.99% from $6.2 million recorded in Q2 2025.
  • Over the past 5 years, InflaRx's Change in Working Capital peaked at $10673.5 billion during Q3 2024, and registered a low of $5.2 million during Q2 2024.
  • Over the past 4 years, InflaRx's median Change in Working Capital value was $6.7 million (recorded in 2023), while the average stood at $889.5 billion.
  • As far as peak fluctuations go, InflaRx's Change in Working Capital surged by 12602635304.17% in 2024, and later tumbled by 9999.99% in 2025.
  • InflaRx's Change in Working Capital (Quarter) stood at $7.6 million in 2022, then grew by 10.89% to $8.5 million in 2023, then skyrocketed by 126026353.04% to $10673.5 billion in 2024, then crashed by 100.0% to $6.3 million in 2025.
  • Its Change in Working Capital stands at $6.3 million for Q3 2025, versus $6.2 million for Q2 2025 and $5.8 million for Q1 2025.